223 related articles for article (PubMed ID: 18507303)
1. Antimicrobial resistance of uncomplicated urinary tract infections in northern Utah.
McQuilkin M; Lund A; Palmer W
Clin Lab Sci; 2008; 21(2):99-101. PubMed ID: 18507303
[TBL] [Abstract][Full Text] [Related]
2. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs.
Moffett SE; Frazee BW; Stein JC; Navab B; Maselli J; Takhar SS; Gonzales R
Am J Emerg Med; 2012 Jul; 30(6):942-9. PubMed ID: 21802879
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care.
McNulty CA; Richards J; Livermore DM; Little P; Charlett A; Freeman E; Harvey I; Thomas M
J Antimicrob Chemother; 2006 Nov; 58(5):1000-8. PubMed ID: 16998209
[TBL] [Abstract][Full Text] [Related]
7. [Distribution and resistance trends of pathogens from urinary tract infections and impact on management].
Shao HF; Wang WP; Zhang XW; Li ZD
Zhonghua Nan Ke Xue; 2003 Dec; 9(9):690-2, 696. PubMed ID: 14727361
[TBL] [Abstract][Full Text] [Related]
8. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
10. Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.
Grude N; Tveten Y; Jenkins A; Kristiansen BE
Scand J Prim Health Care; 2005 Jun; 23(2):115-9. PubMed ID: 16036551
[TBL] [Abstract][Full Text] [Related]
11. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
13. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2.
Stratchounski LS; Rafalski VV
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S4-9. PubMed ID: 16829055
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial susceptibility of organisms infecting the urinary tract in northern Israel].
Oren B; Raz R; Hefter H; Kennes Y; Potasman I
Harefuah; 1991 Jan; 120(2):60-2. PubMed ID: 2007488
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis.
Gupta K; Sahm DF; Mayfield D; Stamm WE
Clin Infect Dis; 2001 Jul; 33(1):89-94. PubMed ID: 11389500
[TBL] [Abstract][Full Text] [Related]
17. [Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus].
Ruxer J; Mozdzan M; Loba J; Markuszewski L
Wiad Lek; 2007; 60(5-6):235-40. PubMed ID: 17966887
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infections in a Saudi Arabian hospital.
Al-Tawfiq JA; Anani AA
Chemotherapy; 2009; 55(2):127-31. PubMed ID: 19188712
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories.
Richards DA; Toop LJ; Chambers ST; Sutherland MG; Harris BH; Ikram RB; Jones MR; McGeoch GR; Peddie B
N Z Med J; 2002 Jan; 115(1146):12-4. PubMed ID: 11936326
[TBL] [Abstract][Full Text] [Related]
20. Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?
Mangin D; Toop L; Chambers S; Ikram R; Harris B
N Z Med J; 2005 Nov; 118(1225):U1726. PubMed ID: 16286940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
